Standout Papers

Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension 2013 2026 2017 2021 928
  1. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension (2013)
    Tomás Pulido, Richard N. Channick et al. New England Journal of Medicine

Immediate Impact

2 from Science/Nature 94 standout
Sub-graph 1 of 16

Citing Papers

Treatment algorithm for pulmonary arterial hypertension
2024 Standout
A systems view of the vascular endothelium in health and disease
2024 Standout
55 intermediate papers

Works of B.K.S. Sastry being referenced

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension
2017
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
2013 Standout
and 6 more

Author Peers

Author Last Decade Papers Cites
B.K.S. Sastry 1604 1152 336 16 1.8k
R. Wiedemann 1368 865 296 17 1.6k
Frédéric Bodin 1209 902 251 43 1.9k
Miguel Ángel Gómez‐Sánchez 1647 1416 332 38 2.3k
Christopher Dufton 1353 973 235 31 1.6k
Michelle Turner 1559 1015 412 25 1.9k
Gilles Garcia 1702 930 407 22 2.1k
Gregory S. Ahearn 1251 973 280 15 2.1k
Zeenat Safdar 2022 1409 341 58 2.3k
Simon Gibbs 1858 1098 378 28 2.2k
Loı̈c Perchenet 1749 1427 340 39 2.2k

All Works

Loading papers...

Rankless by CCL
2026